Added value of ixazomib to lenalidomide plus dexamethasone in transplant-ineligible newly diagnosed MM Presented ByProf. Thierry Facon, University Hospital Lille, France TrialPhase 3, TOURMALINE-MM2 ConferenceASH 2020 TypePeer-reviewed article 18 February 2021 10:37